<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-055424</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Response to idebenone and multivitamin therapy in leber´s hereditary optic neuropathy</dc:title>
<dc:description xml:lang="en">Objective: To ascertain the efficacy of idebenone and multivitamin treatment in Leber&#146;s hereditary    optic neuropathy (LHON).    Method: Two patients diagnosed of unilateral    LHON were treated with megadoses of idebenone,    vitamin C and riboflavin for one year. They were    examined clinically before, during and after treatment.    Results: No improvement of visual function was    observed. Despite the idebenone treatment, in both    cases the second eye became involved.    Conclusions: Despite previous reports of visual    recovery with idebenone in patients with LHON,    our experience shows that an effective treatment for    Leber&#146;s disease remains to be found (AU)</dc:description>
<dc:creator>Barnils, N</dc:creator>
<dc:creator>Mesa, E</dc:creator>
<dc:creator>Ferrer-Artola, A</dc:creator>
<dc:creator>Arruga, J</dc:creator>
<dc:creator>Muñoz, S</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Determinar la eficacia del tratamiento    con idebenona y multivitamínico en la neuropatía    óptica hereditaria de Leber (NOHL).    Método: Dos pacientes diagnosticados de NOHL,    fueron tratados con idebenona, vitamina C y riboflavina    durante un año. Ambos fueron evaluados    clínicamente antes, durante y después del tratamiento.    Resultado: Ninguno de los dos pacientes experimentó    mejoría visual y ambos sufrieron afectación    en el segundo ojo.    Conclusiones: A pesar de casos publicados en la    literatura de recuperación visual con idebenona en    pacientes con NOHL, nuestra experiencia indica    que este tratamiento no es efectivo para la enfermedad    de Leber (AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;82(6): 377-380, jun. 2007. ilus</dc:source>
<dc:identifier>ibc-055424</dc:identifier>
<dc:title xml:lang="es">Respuesta a la idebenona asociada a multivitaminoterapia en neuropatía óptica hereditaria de Leber</dc:title>
<dc:subject>^d36011^s22057</dc:subject>
<dc:subject>^d28872^s22000</dc:subject>
<dc:subject>^d36011^s22012</dc:subject>
<dc:subject>^d28872^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d36011^s22016</dc:subject>
<dc:subject>^d4419</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d27727^s22032</dc:subject>
<dc:subject>^d27728^s22057</dc:subject>
<dc:subject>^d27727^s22012</dc:subject>
<dc:subject>^d27727^s22057</dc:subject>
<dc:subject>^d27728^s22016</dc:subject>
<dc:subject>^d27727^s22016</dc:subject>
<dc:subject>^d27727^s22080</dc:subject>
<dc:subject>^d12665^s22073</dc:subject>
<dc:subject>^d1212^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200706</dc:date>
</metadata>
</record>
</ibecs-document>
